相关实验视频
Updated: Jul 15, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
概括
药房福利管理人员 (PBMs) 正在受到审查. 拟议的法规旨在解决有关其实践和对药物成本的影响的批评.
科学领域:
- 卫生政策 卫生政策
- 制药经济学 制药经济学
背景情况:
- 药房福利管理人员 (PBM) 在药物供应链中发挥着至关重要的作用.
- 药品制药公司面临着越来越多的批评,这些批评涉及其业务实践和对药品定价的影响.
研究的目的:
- 分析针对PBMs提出的批评.
- 评估拟议的监管制PBM运营的潜在有效性.
主要方法:
- 审查关于PBM和药物定价的现有文献.
- 对拟议的立法和监管变更进行分析.
- 检查与PBMs相关的经济模型.
主要成果:
- 批评往往集中在折扣汇总,价格分散和缺乏透明度上.
- 拟议的制措施旨在提高PBM问责制,并可能降低药物成本.
- 限制措施的实际影响将取决于它们的具体设计和执行.
结论:
- 拟议的制措施在缓解PBM相关问题的有效性需要进一步调查.
- 政策干预可能是必要的,以确保公平的药物定价和PBM透明度.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Factors Affecting Drug Distribution: Miscellaneous Factors
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

